Nikhil Prasad Fact checked by:Thailand Medical News Team Jun 10, 2026 2 hours, 2 minutes ago
Medical News: Millions worldwide suffer from inflammatory bowel disease (IBD), a chronic condition that includes ulcerative colitis and Crohn’s disease. These disorders cause recurring inflammation in the digestive tract, leading to symptoms such as abdominal pain, diarrhea, rectal bleeding, fatigue, and a significantly reduced quality of life. While modern treatments have improved disease management, many patients still experience relapses, side effects, or incomplete recovery. Now, a new scientific review is highlighting the remarkable potential of berberine, a natural plant-derived compound, as a multi-target therapy that could help tackle the disease from several directions at once.
Scientists find that berberine may fight inflammatory bowel disease by restoring gut bacteria, calming immune
attacks, and repairing the intestinal barrier
Researchers from the School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine, China, and the Hospital of Chengdu University of Traditional Chinese Medicine, China, examined the growing body of evidence surrounding berberine and its effects on inflammatory bowel disease. Their findings suggest that this natural alkaloid may help restore balance in the gut by simultaneously regulating intestinal bacteria, calming immune system overactivity, and repairing the protective intestinal barrier.
A Natural Compound with Powerful Biological Effects
Berberine is found in medicinal plants such as Coptis chinensis, Phellodendron amurense, and various Berberis species. Although it has traditionally been used in herbal medicine, scientists are now uncovering how it may work at a molecular level.
Interestingly, berberine is poorly absorbed into the bloodstream after oral administration. While this might seem like a disadvantage, researchers believe it could actually be beneficial for intestinal diseases because much of the compound remains in the digestive tract where the inflammation occurs. This allows berberine to interact directly with gut bacteria, intestinal cells, and local immune tissues.
Rebuilding a Healthier Gut Microbiome
One of the most important discoveries highlighted in the review is berberine’s ability to reshape the gut microbiome. Patients with IBD often experience a reduction in beneficial bacteria and an increase in harmful microbes that fuel inflammation.
Studies show that berberine can increase populations of beneficial bacteria such as Akkermansia, Lactobacillus, Bifidobacterium, Bacteroides, and Alistipes while reducing potentially harmful organisms including Escherichia-Shigella, Enterobacteriaceae, Desulfovibrio, and Proteobacteria.
Researchers also found that berberine supports the production of important microbial metabolites, including short-chain fatty acids. These compounds help nourish intestinal cells, strengthen the gut lining, and promote immune tolerance. In addition, berberine appears to influence bile acid metabolism, tryptophan-related pathways, and anti-inflammatory signaling systems that contribute to overall intestinal health.
Calming an Overactive Immune System
IBD develops
partly because the immune system mistakenly attacks tissues within the digestive tract. According to the review, berberine can reduce this excessive immune activity through several interconnected mechanisms.
The compound suppresses major inflammatory pathways that drive the production of cytokines such as TNF-alpha, IL-1 beta, IL-6, IL-17, and interferon-gamma. These inflammatory molecules are heavily involved in tissue damage and disease progression.
At the same time, berberine promotes anti-inflammatory responses by increasing protective molecules such as IL-10 and TGF-beta. It also helps restore balance between pro-inflammatory Th17 immune cells and protective regulatory T cells. This
Medical News report notes that researchers believe these combined effects could reduce chronic intestinal inflammation while encouraging healing.
Another important finding is that berberine encourages macrophages to shift from a highly inflammatory state to a more tissue-repairing and anti-inflammatory state. This may help break the cycle of ongoing damage within the intestinal lining.
Strengthening the Gut’s Protective Barrier
The intestinal barrier acts as a protective wall that prevents harmful microbes and toxins from entering deeper tissues. In IBD, this barrier becomes damaged, allowing inflammatory triggers to penetrate and worsen disease activity.
The review found that berberine helps restore critical tight-junction proteins such as ZO-1, occludin, claudin-1, and JAM-A. These proteins act like seals between intestinal cells and are essential for preventing leaks.
Berberine also supports mucus production by increasing Muc2 expression and helping preserve goblet cells, which produce the mucus layer that protects intestinal surfaces. Additionally, the compound reduces cellular stress and excessive cell death while promoting tissue regeneration and mucosal healing.
New Drug Delivery Systems Could Enhance Benefits
Scientists are also developing advanced delivery systems to maximize berberine’s effectiveness. These include colon-targeted capsules, microbiota-responsive formulations, nanoparticles, hydrogels, and mucoadhesive materials designed to keep berberine concentrated at sites of intestinal inflammation.
Such technologies may improve local drug exposure, strengthen barrier repair, and increase interaction with beneficial gut bacteria while reducing premature drug loss.
Conclusion
The growing body of evidence suggests that berberine may offer a unique and highly promising approach to inflammatory bowel disease treatment. Unlike many existing therapies that focus on a single inflammatory target, berberine appears to work across multiple interconnected systems simultaneously. It helps restore microbial balance, suppress harmful immune responses, strengthen the intestinal barrier, and support tissue repair. Although most of the evidence currently comes from laboratory and animal studies, the early human data are encouraging. Researchers emphasize that larger, well-designed clinical trials are still needed to confirm safety, effectiveness, optimal dosing, and long-term benefits. If future studies validate these findings, berberine could emerge as an important complementary therapy for patients seeking better control of chronic intestinal inflammation.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/12/5220
For the latest on treating inflammatory bowel disease, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/coronavirus
https://www.thailandmedical.news/articles/gastroenterology
Share
Tweet
Share
